Jason Hoitt's Net Worth
$257 Thousand
Who is Jason Hoitt?
Jason Hoitt does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Provention Bio, Inc., and Dova Pharmaceuticals Inc..
SEC CIK
Jason Hoitt's CIK is 0001762572
Past Insider Trading and Trends
2020 was Jason Hoitt's most active year for acquiring shares with 3 total transactions. Jason Hoitt's most active month to acquire stocks was the month of November. 2019 was Jason Hoitt's most active year for disposing of shares, totalling 8 transactions. Jason Hoitt's most active month to dispose stocks was the month of March. 2020 saw Jason Hoitt paying a total of $24,435.00 for 542,250 shares, this is the most they've acquired in one year. In 2019 Jason Hoitt cashed out on 274,711 shares for a total of $236,397.48, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Provention Bio, Inc. No price found
Chief Commercial OfficerJason Hoitt used to own units in Common Stock but no longer holds any shares there. In the year 2020 Jason Hoitt filed a total of 10 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 27
| |||
Form 4
| -100.00% | -4.50K |
$10.00 | -$45,005.40 |
0
|
Scheduled
|
Feb 10
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
∞
| 4.5K |
$5.43 | $24,435.00 | 4.5K |
Mar 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
| No matching records found | |||||||||
Dova Pharmaceuticals Inc. No price found
Chief Commercial OfficerJason Hoitt used to own units in Common Stock but no longer holds any shares there. In the year 2018 Jason Hoitt filed a total of 7 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -9.97K |
—
|
—
|
0
|
Nov 12
| |||
Form 4
| -19.32% | -2.39K |
$28.00 | -$66,836.00 | 9.97K |
Scheduled
|
Sep 30
| ||
Form 4
| -38.02% | -7.58K |
$15.26 | -$115,664.00 | 12.36K |
Scheduled
|
Jul 15
| ||
Form 4
| -10.69% | -2.39K |
$13.81 | -$32,963.49 | 19.94K |
Scheduled
|
Jun 28
| ||
Form 4
| -9.66% | -2.39K |
$8.77 | -$20,933.99 | 22.32K |
Scheduled
|
Apr 8
| ||
Form 4
|
∞
| 24.71K |
—
|
—
| 24.71K |
Dec 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||